Back to top

earnings-outlook: Archive

Zacks Equity Research

Synopsys (SNPS) Lags Q3 Earnings and Revenue Estimates

Synopsys (SNPS) delivered earnings and revenue surprises of -11.72% and -1.61%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

SNPSPositive Net Change PRGSPositive Net Change

Zacks Equity Research

GameStop (GME) Q2 Earnings and Revenues Beat Estimates

GameStop (GME) delivered earnings and revenue surprises of +31.58% and +8.02%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

GMEPositive Net Change HOFTNegative Net Change

Zacks Equity Research

All You Need to Know About WSFS (WSFS) Rating Upgrade to Buy

WSFS (WSFS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

WSFSNegative Net Change

Zacks Equity Research

REV Group (REVG) Upgraded to Buy: What Does It Mean for the Stock?

REV Group (REVG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

REVGPositive Net Change

Zacks Equity Research

IZEA WORLDWIDE (IZEA) Upgraded to Buy: Here's What You Should Know

IZEA WORLDWIDE (IZEA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

IZEANegative Net Change

Zacks Equity Research

Bank OZK (OZK) Upgraded to Buy: Here's What You Should Know

Bank OZK (OZK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

OZKNegative Net Change

Zacks Equity Research

All You Need to Know About Swire Pacific (SWRAY) Rating Upgrade to Buy

Swire Pacific (SWRAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SWRAYNegative Net Change

Zacks Equity Research

Enliven Therapeutics, Inc. (ELVN) Upgraded to Buy: Here's What You Should Know

Enliven Therapeutics, Inc. (ELVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ELVNPositive Net Change

Zacks Equity Research

Compass Group (CMPGY) Upgraded to Buy: Here's What You Should Know

Compass Group (CMPGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CMPGYNegative Net Change

Zacks Equity Research

What Makes Farmer Mac (AGM) a New Buy Stock

Farmer Mac (AGM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AGMNegative Net Change

Zacks Equity Research

All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy

Seres Therapeutics (MCRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MCRBNegative Net Change

Zacks Equity Research

SouthState (SSB) Upgraded to Buy: What Does It Mean for the Stock?

SouthState (SSB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SSBNegative Net Change

Kaibalya Pravo Dey

UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?

UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.

UNHPositive Net Change BRK.BPositive Net Change MOHPositive Net Change CNCPositive Net Change

Zacks Equity Research

Want Better Returns? Don't Ignore These 2 Construction Stocks Set to Beat Earnings

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

KBHNegative Net Change DYPositive Net Change

Zacks Equity Research

These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

RHNegative Net Change KMBNegative Net Change

Zacks Equity Research

FuelCell Energy (FCEL) Reports Q3 Loss, Tops Revenue Estimates

FuelCell Energy (FCEL) delivered earnings and revenue surprises of +40.25% and +6.55%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

FCELPositive Net Change EPMNegative Net Change

Zacks Equity Research

Core & Main (CNM) Q2 Earnings Surpass Estimates

Core & Main (CNM) delivered earnings and revenue surprises of +12.99% and -1.29%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

CNMNegative Net Change AZZPositive Net Change

Zacks Equity Research

Designer Brands (DBI) Tops Q2 Earnings Estimates

Designer Brands (DBI) delivered earnings and revenue surprises of +54.55% and -1.10%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

DBINegative Net Change SFIXNegative Net Change

Zacks Equity Research

Korn/Ferry (KFY) Q1 Earnings and Revenues Surpass Estimates

Korn/Ferry (KFY) delivered earnings and revenue surprises of +5.65% and +3.43%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

KFYNegative Net Change AYIPositive Net Change

Zacks Equity Research

What Makes York Water (YORW) a New Buy Stock

York Water (YORW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

YORWPositive Net Change

Zacks Equity Research

Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?

Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STTKPositive Net Change

Zacks Equity Research

What Makes Tilly's (TLYS) a New Buy Stock

Tilly's (TLYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TLYSPositive Net Change

Zacks Equity Research

All You Need to Know About Exponent (EXPO) Rating Upgrade to Buy

Exponent (EXPO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

EXPOPositive Net Change

Zacks Equity Research

MUFG (MUFG) Upgraded to Strong Buy: Here's What You Should Know

MUFG (MUFG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MUFGPositive Net Change

Zacks Equity Research

1st Source (SRCE) Upgraded to Strong Buy: Here's Why

1st Source (SRCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SRCENegative Net Change